Right bundle-branch block

I9_RBBB

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I45.0, I45.1 Hospital discharge: ICD-9 — 4264 Cause of death: ICD-10 — I45.0, I45.1 Cause of death: ICD-9 — 4264 2 out of 7 registries used, show all original rules.	1756
4. Check minimum number of events None	1756
5. Include endpoints None	1756
6. Filter based on genotype QC (FinnGen only)	1586

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	I9_RBBB
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I45[0-1]
HD_ICD_9	4264
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I45[0-1]
COD_ICD_9	4264
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Right bundle-branch block based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9484	3939	5460
Only index persons	7783	3301	4482
Unadjusted period prevalence (%)
Whole population	0.14	0.11	0.15
Only index persons	0.15	0.12	0.17
Median age at first event (years)
Whole population	68.95	70.74	67.60
Only index persons	67.26	68.85	66.09

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1586	594	992
Unadjusted period prevalence (%)	0.36	0.21	0.45
Median age at first event (years)	67.50	64.63	69.22

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1629: Matched controls
16290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

107.2

318.8

164

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

399.5

307.7

321

I45.0

ICD-10 Finland

Right fascicular block

1001.2

307.7

878

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

9.6

307.7

711

1218

I45.1

ICD-10 Finland

Other and unspecified right bundle-branch block

929.9

307.7

778

I50.0

ICD-10 Finland

Congestive heart failure

104.4

307.7

177

207

Kela drug reimbursment

Chronic arrhythmias

262.4

307.7

300

I50.9

ICD-10 Finland

Heart failure, unspecified

47.7

307.7

341

I48

ICD-10 Finland

Atrial fibrillation and flutter

115.5

307.7

464

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

305.1

283

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

333.0

255.8

253

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

87.5

244.6

129

XF404

NOMESCO Finland

Ambulatory ECG

12.6

229.8

239

219

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

6.1

215.5

459

977

I44.0

ICD-10 Finland

Atrioventricular block, first degree

58.8

213.5

120

I49.3

ICD-10 Finland

Ventricular premature depolarization

16.4

211.4

185

126

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

572.8

207.8

202

B01AA03

ATC

warfarin; systemic

6.3

199.0

397

790

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

+∞

183.9

173

I35.0

ICD-10 Finland

Aortic (valve) stenosis

31.2

180.6

119

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

46.7

178.1

105

K78

ICPC

Atrial fibrillation/flutter

18.8

169.7

137

C01AA05

ATC

digoxin; systemic

14.2

169.5

160

124

B01AF02

ATC

apixaban; oral

7.8

154.9

233

342

I48.1

ICD-10 Finland

Persistent atrial fibrillation

77.4

150.9

C07AB07

ATC

bisoprolol; oral

3.5

137.3

929

4436

I47.1

ICD-10 Finland

Supraventricular tachycardia

39.2

133.4

TFP20

NOMESCO Finland

Cardiodefibrillation

208.4

130.8

134

I44.2

ICD-10 Finland

Atrioventricular block, complete

1351.8

130.0

125

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

280.0

128.1

129

C03CA01

ATC

furosemide; systemic

3.4

118.6

625

2509

I50.1

ICD-10 Finland

Left ventricular failure

401.2

114.0

113

201

Kela drug reimbursment

Chronic cardiac insufficiency

11.3

109.4

118

112

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

5.8

108.5

216

418

R06.0

ICD-10 Finland

Dyspnoea

3.2

99.6

570

2364

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.4

99.6

468

1725

I50

ICD-10 Finland

Heart failure

24.8

97.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

95.0

932

5153

XF402

NOMESCO Finland

ECG with work load test

4.6

94.3

253

630

I44.1

ICD-10 Finland

Atrioventricular block, second degree

201.6

92.4

C03DA01

ATC

spironolactone; oral

4.5

90.6

247

622

I48.2

ICD-10 Finland

Chronic atrial fibrillation

462.1

89.1

I49.5

ICD-10 Finland

Sick sinus syndrome

124.6

87.9

J45.1

ICD-10 Finland

Nonallergic asthma

5.0

84.0

197

438

I49.1

ICD-10 Finland

Atrial premature depolarization

12.0

77.1

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

121.7

75.6

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

5.1

75.6

168

356

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.3

73.6

208

535

J45.9

ICD-10 Finland

Asthma, unspecified

3.0

72.9

401

1590

R00.1

ICD-10 Finland

Bradycardia, unspecified

9.0

69.7

103

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.9

69.5

422

1762

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

68.1

559

2716

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

21.0

67.3

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

60.8

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.5

60.0

520

2567

XF400

NOMESCO Finland

ECG with 12 standard connections

2.9

59.3

333

1322

I45.2

ICD-10 Finland

Bifascicular block

155.6

57.3

K77

ICPC

Heart failure

19.6

56.4

J46

ICD-10 Finland

Status asthmaticus

7.3

56.3

120

XF640, ,

NOMESCO Finland

9.8

55.4

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

285.6

54.5

TFP34

NOMESCO Finland

Electrophysiological investigation

285.6

54.5

C07AA07

ATC

sotalol; systemic

7.8

54.2

101

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

52.2

317

1305

I44.4

ICD-10 Finland

Left anterior fascicular block

182.5

51.2

H02AB06

ATC

prednisolone; systemic

2.2

50.9

827

5236

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

49.5

393

1841

4264A

ICD-9 Finland

Conduction disorders, Right bundle branch block

+∞

48.2

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.4

47.7

437

2178

R03AC12

ATC

salmeterol; inhalant

4.3

46.8

126

310

C01BD01

ATC

amiodarone; systemic

76.8

46.2

I45.9

ICD-10 Finland

Conduction disorder, unspecified

103.1

46.0

C01BC04

ATC

flecainide; systemic

98.9

44.0

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.5

43.1

158

483

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

96.8

43.0

C08DA01

ATC

verapamil; systemic

5.6

42.2

153

SPAT1263

SPAT

Sampling

2.1

42.1

688

4277

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.6

42.0

282

1212

I47.2

ICD-10 Finland

Ventricular tachycardia

115.6

41.9

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

41.8

AA1AD

NOMESCO Finland

CT of head and brain

2.1

41.6

548

3141

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

61.8

41.4

K80

ICPC

Cardiac arrhythmia NOS

3.7

41.4

138

396

I10

ICD-10 Finland

Essential (primary) hypertension

2.1

41.1

1101

8139

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

54.9

40.7

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

8.1

40.6

C01DA14

ATC

isosorbide mononitrate; oral

2.5

40.4

313

1437

R55

ICD-10 Finland

Syncope and collapse

2.7

39.6

233

935

G47.3

ICD-10 Finland

Sleep apnoea

2.2

38.8

405

2110

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.5

38.3

227

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

6.8

37.5

R03DC03

ATC

montelukast; oral

2.5

37.5

273

1215

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

37.2

389

2024

R03BA05

ATC

fluticasone; inhalant

2.4

37.0

313

1489

AS4

Physiological pacemaker insertion DDD (R)

+∞

36.6

R00.2

ICD-10 Finland

Palpitations

3.6

36.3

127

376

H02AB04

ATC

methylprednisolone; systemic

2.5

35.2

261

1169

I45.3

ICD-10 Finland

Trifascicular block

183.9

34.9

J45.8

ICD-10 Finland

Mixed asthma

4.8

34.8

177

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

126.1

34.8

R03AC02

ATC

salbutamol; inhalant

1.9

34.6

827

5735

R03DA04

ATC

theophylline; systemic, rectal

3.3

34.6

137

439

N02BE01

ATC

paracetamol; systemic, rectal

2.5

33.2

1432

12105

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

33.1

470

2730

C09AA05

ATC

ramipril; oral

2.0

33.1

440

2496

PD5AD

NOMESCO Finland

CT of aorta

6.6

32.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

32.5

513

3087

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

323.2

32.0

R53

ICD-10 Finland

Malaise and fatigue

2.1

32.0

413

2314

J01MA12

ATC

levofloxacin; systemic

2.2

31.9

346

1815

R03BA02

ATC

budesonide; inhalant

2.2

31.5

297

1473

R02

ICPC

Shortness of breath/dyspnoea

2.4

30.5

228

1021

AQ1

Conventional electrophysiological examination

+∞

30.3

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

+∞

30.3

B01AF01

ATC

rivaroxaban; oral

2.5

29.9

205

882

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

307.9

29.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

29.5

315

1638

K99

ICPC

Cardiovascular disease other

5.6

29.2

103

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

28.9

475

2878

A02BC02

ATC

pantoprazole; systemic

1.8

28.8

1082

8429

J45

ICD-10 Finland

Asthma

2.6

28.8

177

722

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.1

28.8

210

GD1LA

NOMESCO Finland

44.6

28.7

I20.09

ICD-10 Finland

Unstable angina

3.3

28.7

114

365

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

28.7

203

886

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

4.7

27.9

142

R03BB04

ATC

tiotropium bromide; inhalant

2.4

27.9

205

910

N02AX02

ATC

tramadol; systemic, rectal

1.8

27.7

716

4974

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

27.7

365

2047

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

29.1

27.7

ZXD05

NOMESCO Finland

Urgent procedure

1.9

27.4

452

2734

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.5

27.0

R42

ICD-10 Finland

Dizziness and giddiness

1.9

26.9

402

2352

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.9

26.6

135

498

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

5.6

26.4

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

26.3

314

1696

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

26.2

235

1136

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.1

26.2

184

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

26.2

360

2045

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

26.1

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

26.1

AN1

Coronary angiography

2.5

26.0

177

757

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

6.3

25.9

C08DB01

ATC

diltiazem; oral

3.1

25.3

108

361

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

25.1

J01DB01

ATC

cefalexin; oral

1.9

24.7

1262

10519

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

24.7

213

1011

B01AE07

ATC

dabigatran etexilate; oral

5.0

24.7

108

A46

ICD-10 Finland

Erysipelas

2.1

24.6

258

1325

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.5

24.6

259

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.5

24.2

247

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.7

24.1

214

M04AA01

ATC

allopurinol; systemic

2.2

23.8

237

1193

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

23.7

114

408

Angiography of the heart and coronary arteries

2.9

23.6

115

415

R03BA01

ATC

beclometasone; inhalant

2.2

23.6

225

1113

R03AK08

ATC

formoterol and beclometasone; inhalant

3.5

23.5

252

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

23.5

113

405

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.8

23.3

119

440

J01FF01

ATC

clindamycin; systemic

1.8

23.1

413

2543

R03AC13

ATC

formoterol; inhalant

3.1

23.0

327

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

23.0

271

1451

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

23.0

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

23.0

WX892

NOMESCO Finland

Monitored bed care

2.7

22.6

124

477

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

22.4

451

2876

SPAT1262

SPAT

Handing over of treatment supplies

1.9

22.2

314

1790

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

6.7

22.2

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.4

22.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

22.1

615

4290

R96

ICPC

Asthma

2.4

21.9

165

738

I34.1

ICD-10 Finland

Mitral (valve) prolapse

29.5

21.9

TFP35

NOMESCO Finland

Electroanatomical mapping

81.3

21.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

21.6

206

1017

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

21.5

199

970

H02AB07

ATC

prednisone; oral

2.1

21.5

235

1223

M79.6

ICD-10 Finland

Pain in limb

1.7

21.4

654

4664

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

21.4

204

1007

C07AB02

ATC

metoprolol; systemic

1.9

21.2

311

1792

A12BA01

ATC

potassium chloride; oral

3.4

21.2

228

J01CA04

ATC

amoxicillin; systemic

1.8

21.2

1204

10068

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

20.9

221

1135

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

20.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

20.8

605

4250

UJF32

NOMESCO Finland

Coloscopy

1.8

20.8

431

2762

SPAT1104

SPAT

Monitoring of emergency patient

2.7

20.8

115

444

SPAT1097

SPAT

Recording of ECG

2.1

20.7

232

1217

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.5

20.7

212

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

20.6

103

377

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.3

20.4

168

780

A02BC05

ATC

esomeprazole; systemic

1.7

20.3

609

4308

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

20.3

122

491

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

20.2

341

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

20.1

187

914

M54.5

ICD-10 Finland

Low back pain

1.7

20.1

525

3581

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.6

19.9

116

459

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.8

19.9

103

384

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

19.8

226

1192

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

106.3

19.6

R50.9

ICD-10 Finland

Fever, unspecified

2.0

19.2

245

1345

C08CA01

ATC

amlodipine; oral

1.6

19.0

641

4648

SPAT1254

SPAT

Administration of medicine

2.0

19.0

243

1335

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

19.0

296

1736

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

18.8

R07.3

ICD-10 Finland

Other chest pain

2.2

18.8

170

821

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

5.7

18.7

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

101.2

18.6

R03DC01

ATC

zafirlukast; oral

4.9

18.5

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

18.5

646

4717

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

30.4

18.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

18.3

450

3006

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

18.3

390

2507

K84

ICPC

Heart disease other

4.3

18.2

112

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

18.2

510

3525

J96.1

ICD-10 Finland

Chronic respiratory failure

4.1

18.2

125

E66.00

ICD-10 Finland

Metabolic syndrome

2.8

18.1

345

XG410

NOMESCO Finland

Flow-volume spirometry

3.2

18.1

236

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.7

18.1

100

386

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

18.0

230

1261

I20.00

ICD-10 Finland

Unstable angina

3.6

18.0

167

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

17.9

195

1011

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

17.8

180

907

250, ,

Kela drug reimbursment

20.3

17.8

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

17.7

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

17.7

I48.3

ICD-10 Finland

Typical atrial flutter

+∞

17.7

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

17.7

604

4374

R60.0

ICD-10 Finland

Localized oedema

2.0

17.6

212

1139

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

17.5

301

1814

M10.9

ICD-10 Finland

Gout, unspecified

2.4

17.4

121

521

R03AC03

ATC

terbutaline; inhalant

2.0

17.4

205

1092

B01AB05

ATC

enoxaparin; parenteral

1.6

17.3

473

3240

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

17.2

631

4642

SPAT1260

SPAT

Consultation of another employee

1.9

17.2

263

1530

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.2

17.1

223

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

17.1

527

3716

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

16.9

559

4007

K04

ICPC

Palpitations/awareness of heart

3.2

16.7

221

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

16.7

WX872

NOMESCO Finland

Intensive care

3.0

16.7

248

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

16.7

402

2662

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

16.6

114

489

N03AX16

ATC

[U] pregabalin

1.7

16.5

348

2221

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.8

16.4

311

I25.2

ICD-10 Finland

Old myocardial infarction

2.5

16.4

111

472

H25.8

ICD-10 Finland

Other senile cataract

1.9

16.4

225

1262

N19

ICD-10 Finland

Unspecified kidney failure

3.1

16.4

224

K83

ICPC

Heart valve disease NOS

40.5

16.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

16.3

455

3124

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

16.2

236

1350

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

16.1

502

3539

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

16.1

132

612

J01MA02

ATC

ciprofloxacin; systemic

1.6

15.9

632

4710

A10BA02

ATC

metformin; oral

1.6

15.8

473

3302

XG466

NOMESCO Finland

Sleep oxymetry

3.7

15.7

139

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.6

15.7

378

C09DX04

ATC

valsartan and sacubitril; oral

+∞

15.6

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

15.6

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

15.6

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

15.6

J01FA06

ATC

roxithromycin; oral

1.6

15.6

562

4093

S18

ICPC

Laceration/cut

1.5

15.5

737

5703

OAB50, ,

SPAT

2.1

15.5

150

742

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

15.4

254

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.0

15.4

238

SPAT1312

SPAT

General health counselling

1.6

15.3

445

3079

R03BA08

ATC

ciclesonide; inhalant

2.3

15.3

120

546

R03BB01

ATC

ipratropium bromide; inhalant

2.7

15.2

318

SPAT1310

SPAT

Counselling related to known health issue

1.6

15.0

465

3263

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

15.0

1025

8547

C10AA01

ATC

simvastatin; oral

1.5

15.0

703

5412

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

15.0

542

3942

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

15.0

109

479

J01AA02

ATC

doxycycline; systemic

1.6

15.0

1164

9989

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

14.9

580

4287

A04

ICPC

Weakness/tiredness general

1.8

14.9

231

1345

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.6

14.8

334

J01FA09

ATC

clarithromycin; systemic

1.6

14.8

410

2801

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

14.7

207

1169

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.0

14.7

217

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

14.6

428

2961

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

14.6

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

14.6

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

14.6

C10AA05

ATC

atorvastatin; oral

1.5

14.5

669

5121

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.0

14.5

219

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

14.4

716

5567

L17

ICPC

Foot/toe symptom/complaint

1.6

14.3

447

3139

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

11.5

14.3

A10BH05

ATC

linagliptin; oral

2.5

14.3

395

R06AE07

ATC

cetirizine; oral

1.5

14.3

575

4274

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

14.2

168

894

K05

ICPC

Irregular heartbeat other

3.7

14.2

120

B01AC04

ATC

clopidogrel; oral

1.7

14.2

276

1718

T90

ICPC

Diabetes non-insulin dependent

1.6

14.1

397

2717

M03BX02

ATC

tizanidine; oral

1.5

14.1

838

6749

A11

ICPC

Chest pain NOS

2.1

14.1

138

686

E0000UV, ,

ATC

1.5

14.1

594

4456

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.2

14.0

122

579

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

13.9

162

858

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

53.8

13.8

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.4

13.8

389

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

20.2

13.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

13.7

377

2563

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

13.6

298

1912

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

+∞

13.6

I51.4

ICD-10 Finland

Myocarditis, unspecified

+∞

13.6

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

13.5

405

2810

R01AD08

ATC

fluticasone; nasal

1.6

13.5

380

2597

A10AB05

ATC

insulin aspart; parenteral

2.2

13.5

123

595

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

13.4

130

643

A02BC01

ATC

omeprazole; systemic

1.6

13.3

407

2836

Catheterization and pressure measurement of the left side of the heart

4.2

13.2

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

13.2

752

5975

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

13.2

250

1542

B01AF03

ATC

edoxaban; oral

10.1

13.0

R01AD09

ATC

mometasone; nasal

1.5

13.0

576

4350

A10BK03

ATC

empagliflozin; oral

1.9

12.9

160

866

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

12.8

151

803

S97

ICPC

Chronic ulcer skin

2.2

12.8

104

480

P01AB01

ATC

metronidazole; oral, rectal

1.5

12.6

537

4014

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

12.5

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

12.5

AS2

Ventricular pacemaker insertion VVI (R)

+∞

12.5

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

12.5

XF409

NOMESCO Finland

Other special ECG

20.2

12.5

N03AX12

ATC

[U] gabapentin; oral

1.7

12.4

234

1442

R05

ICPC

Cough

1.6

12.3

349

2383

SPAT1211

SPAT

Application of soft bandage

2.0

12.3

134

692

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

12.2

174

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.1

12.2

169

SPAT1255

SPAT

Intravenous administration of medicine

2.2

12.2

106

503

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

16.0

12.1

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

12.1

266

1707

A01

ICPC

Pain general/multiple sites

1.9

12.0

157

864

N06AX11

ATC

mirtazapine; oral

1.5

12.0

481

3544

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

12.0

284

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

3.9

11.9

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

11.8

342

2345

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

11.8

155

855

X58

ICD-10 Finland

Exposure to other specified factors

1.8

11.7

200

1195

J01FA10

ATC

azithromycin; systemic

1.4

11.6

723

5796

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

11.6

221

1362

C09AA02

ATC

enalapril; systemic

1.6

11.6

308

2068

SPAT1325

SPAT

Vaccination

1.5

11.6

507

3797

R03BC03

ATC

nedocromil; inhalant

2.2

11.6

102

486

49300

ICD-8 Finland

Asthma, bronchiale

3.2

11.6

148

A10AC01

ATC

insulin (human); parenteral

2.0

11.5

120

611

C01BC03

ATC

propafenone; systemic

+∞

11.5

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

11.5

AQ2

Electrophysiological electroanatomical examination

+∞

11.5

Initial pacemaker installation

+∞

11.5

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

11.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

11.4

141

761

G44.2

ICD-10 Finland

Tension-type headache

1.8

11.4

172

990

L28

ICPC

Limited function/disability (L)

1.6

11.4

303

2035

ZXE00

NOMESCO Finland

One hour or less

1.5

11.4

520

3927

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.4

11.4

C01BA03

ATC

disopyramide; systemic

35.3

11.3

SPAT1216

SPAT

Assessment of functional ability

1.6

11.3

256

1654

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

11.2

132

701

E87.5

ICD-10 Finland

Hyperkalaemia

3.9

11.2

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

4.6

11.2

A10AE04

ATC

insulin glargine; parenteral

1.9

11.1

151

842

WX722

NOMESCO Finland

PEEP

2.5

11.1

289

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.2

11.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

11.1

217

1348

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

11.0

158

897

Z3231

NOMESCO Finland

Registered nurse

1.5

11.0

385

2752

A98

ICPC

Health maint/preventive medicine

1.7

10.9

1452

13438

WX002

NOMESCO Finland

Sedation and analgesia

1.6

10.9

281

1872

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

10.9

187

1120

A10BK01

ATC

dapagliflozin; oral

2.1

10.8

110

555

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.7

10.8

227

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

10.8

251

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

17.9

10.7

UJF92

NOMESCO Finland

Capsular endoscopy

3.7

10.7

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

10.7

128

684

M02AA07

ATC

piroxicam; topical

1.5

10.6

522

3988

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

10.6

199

1222

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

10.5

296

SPAT1285

SPAT

Provision of consultation response

2.2

10.5

385

N05CF01

ATC

zopiclone; oral

1.5

10.5

473

3550

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

10.5

225

1430

R04.0

ICD-10 Finland

Epistaxis

2.0

10.5

108

547

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.8

10.5

A10BX07

ATC

[U] liraglutide

4.7

10.5

W19

ICD-10 Finland

Unspecified fall

1.8

10.4

148

836

SPAT1058

SPAT

PEF monitoring instruction

2.0

10.4

114

590

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

10.4

179

1071

TFJ02

NOMESCO Finland

Muscle biopsy of heart

110.7

10.4

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

10.4

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

10.4

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

10.4

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

10.4

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

10.4

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

10.4

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

+∞

10.4

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.6

10.4

243

C09CA03

ATC

valsartan; oral

1.9

10.3

143

802

C08CA13

ATC

lercanidipine; oral

1.7

10.3

213

1341

C01CA24

ATC

epinephrine; parenteral

2.3

10.3

337

R06AX27

ATC

desloratadine; oral

1.5

10.3

328

2293

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

10.1

244

1598

C09CA01

ATC

losartan; oral

1.5

10.1

383

2775

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

10.1

209

1317

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

10.1

127

691

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

10.0

242

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

10.0

497

3796

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

10.0

101

509

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

10.0

145

826

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

9.9

131

723

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

9.9

196

B80

ICPC

Iron deficiency anaemia

3.2

9.9

120

SPAT1281

SPAT

Other administrative function

2.0

9.9

116

616

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

9.9

262

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

9.8

377

2736

SPAT1301

SPAT

No procedures

1.5

9.8

445

3337

K02.1

ICD-10 Finland

Caries of dentine

1.4

9.8

767

6338

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

9.8

158

928

Z2446

NOMESCO Finland

Social worker

2.1

9.8

437

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

8.8

9.8

Z01.2

ICD-10 Finland

Dental examination

1.4

9.8

596

4720

UKC02

NOMESCO Finland

Cystoscopy

1.6

9.8

283

1935

SPAT1229

SPAT

Assessment of need for aid

1.9

9.7

119

641

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

9.7

221

1427

ZX120

NOMESCO Finland

Intravenous

1.9

9.6

133

745

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

9.5

462

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

9.5

435

K29

ICPC

Cardiovascular sympt/complt other

2.3

9.5

304

205

Kela drug reimbursment

Chronic hypertension

1.5

9.5

430

3222

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.1

9.4

129

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

100.6

9.4

Electrophysiological Special Examination

100.6

9.4

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

9.4

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

+∞

9.4

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

+∞

9.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

9.4

486

PD4AD

NOMESCO Finland

CT of lower extremity arteries

5.2

9.4

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.0

9.3

494

R4110, ,

SPAT

1.7

9.3

198

1256

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.6

9.3

203

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

9.3

245

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

9.3

152

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

9.3

270

R03AK11

ATC

formoterol and fluticasone; inhalant

3.1

9.2

120

A10AE05

ATC

insulin detemir; parenteral

2.2

9.2

380

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.2

9.2

110

J01DA01

ATC

[U] cefalexin

1.4

9.2

864

7333

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

9.2

191

1205

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.7

9.2

187

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

9.1

393

2914

SPAT1153

SPAT

Removal of sutures

1.4

9.1

466

3567

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

9.1

349

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

9.1

291

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

9.1

153

910

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

9.1

464

-48

ICPC

Clarification/discussion RFE/demand

3.4

9.1

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

9.0

186

1169

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.4

9.0

249

JN4AD

NOMESCO Finland

Body CT examination

1.7

9.0

183

1148

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

8.9

115

630

J37.0

ICD-10 Finland

Chronic laryngitis

2.5

8.9

231

SPAT1236

SPAT

Informing family of child’s disability

3.0

8.9

128

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

24.1

8.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

8.9

127

719

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

8.9

209

1358

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

8.9

320

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

8.9

111

603

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

8.9

263

B01AC06

ATC

acetylsalicylic acid; oral

2.5

8.9

214

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

8.9

161

979

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

4.9

8.8

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

8.8

224

1484

K30

ICD-10 Finland

Functional dyspepsia

1.8

8.8

147

873

S29

ICPC

Skin symptom/complaint other

1.5

8.8

295

2080

J05AB01

ATC

aciclovir; systemic

1.5

8.8

290

2038

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

8.7

429

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

8.7

166

1022

M48.0

ICD-10 Finland

Spinal stenosis

1.6

8.7

194

1244

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.9

8.7

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.9

8.7

106

571

C08CA02

ATC

felodipine; oral

1.8

8.7

142

838

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

8.7

862

7352

H03AA01

ATC

levothyroxine sodium; systemic

1.5

8.7

291

2051

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

8.6

390

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.1

8.6

390

WX882

NOMESCO Finland

High dependency care

2.8

8.6

147

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

8.6

187

C02DE01, ,

ATC

4.8

8.6

J47

ICD-10 Finland

Bronchiectasis

2.9

8.6

131

N05BA12

ATC

alprazolam; oral

1.8

8.5

134

781

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

8.5

230

1544

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

8.5

128

737

160

Kela drug reimbursment

exenatide

3.3

8.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

8.5

147

882

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.4

8.5

256

Z2221

NOMESCO Finland

Medical doctor

1.5

8.4

349

2564

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

90.5

8.4

I45.6

ICD-10 Finland

Pre-excitation syndrome

90.5

8.4

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

8.4

172

1079

L03

ICPC

Low back symptom/complaint

1.4

8.4

379

2832

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

8.3

AP4

Myocardial biopsy

+∞

8.3

AB2

AVR bio, stent

+∞

8.3

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

8.3

110

608

A10BH01

ATC

sitagliptin; oral

1.7

8.3

149

903

R29

ICPC

Respiratory symptom/complaint other

2.0

8.3

494

R31

ICD-10 Finland

Unspecified haematuria

1.7

8.3

173

1092

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

8.3

A11CC03

ATC

alfacalcidol; systemic

3.3

8.2

Z3226

NOMESCO Finland

Physiotherapist

1.5

8.2

243

1666

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

8.2

532

K03.66

ICD-10 Finland

Tooth plaque

1.8

8.2

113

634

R04.2

ICD-10 Finland

Haemoptysis

2.4

8.2

235

J96.0

ICD-10 Finland

Acute respiratory failure

3.9

8.2

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

8.2

325

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

8.2

406

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

8.1

333

2439

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.6

8.1

187

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.2

8.1

306

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

8.1

143

863

M10

ICD-10 Finland

Gout

2.2

8.1

333

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.1

101

549

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

8.0

949

8269

E66.8

ICD-10 Finland

Other obesity

2.4

8.0

243

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

8.0

351

2603

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

6.3

8.0

J02AC01

ATC

fluconazole; systemic

1.4

8.0

432

3326

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

4.2

8.0

A06AD11

ATC

lactulose; oral

1.5

8.0

251

1742

S22.3

ICD-10 Finland

Fracture of rib

1.8

8.0

114

646

A01AB04

ATC

amphotericin B; local oral

2.1

8.0

355

K07

ICPC

Swollen ankles/oedema

2.1

8.0

335

N06AB04

ATC

citalopram; systemic

1.5

8.0

276

1956

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.4

7.9

238

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.5

7.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

7.9

257

1797

A28

ICPC

Limited function/disability NOS

1.5

7.9

287

2053

A10BB12

ATC

glimepiride; oral

1.8

7.9

115

656

R05

ICD-10 Finland

Cough

1.5

7.9

282

2011

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

7.9

495

3909

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.5

7.9

196

R11

ICD-10 Finland

Nausea and vomiting

1.8

7.9

113

642

C08CA05

ATC

nifedipine; systemic

1.9

7.8

475

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.7

7.8

155

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

7.8

111

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

7.8

173

A02BA02

ATC

ranitidine; systemic

1.5

7.8

281

2007

A02BC03

ATC

lansoprazole; oral

1.4

7.8

404

3088

Z01.7

ICD-10 Finland

Laboratory examination

1.5

7.8

219

1484

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

7.8

305

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

7.7

238

1645

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

7.7

195

1289

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

7.7

168

A10BJ01

ATC

exenatide; parenteral

4.5

7.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

7.7

233

1606

R03BC01

ATC

cromoglicic acid; inhalant

3.7

7.6

K02

ICPC

Pressure/tightness of heart

2.8

7.6

140

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

7.6

304

2213

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

7.6

516

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.8

7.6

129

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

25.1

7.6

L15

ICPC

Knee symptom/complaint

1.4

7.6

341

2540

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

7.6

206

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

7.5

217

1477

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

7.5

194

SPAT1167

SPAT

Insertion of urinary catheter

2.2

7.5

276

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.3

7.5

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

7.5

264

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

7.5

364

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.6

7.5

159

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

2.8

7.5

125

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

7.4

399

D82

ICPC

Teeth/gum disease

1.4

7.4

457

3590

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

80.5

7.4

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.8

7.4

131

NHQ40

NOMESCO Finland

Amputation of toe

3.4

7.4

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.4

7.4

N05BA04

ATC

oxazepam; oral

1.4

7.4

353

2656

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

7.4

227

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.4

347

2604

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

7.4

240

A07AA02

ATC

nystatin; oral

1.9

7.4

450

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

7.4

252

1780

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

7.3

100

559

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

7.3

472

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.1

7.3

FN1AD

NOMESCO Finland

CT of coronary arteries

3.6

7.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.1

7.3

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

7.3

Initial installation of the atrial pacemaker

+∞

7.3

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

7.3

FMD22

NOMESCO Finland

Percutaneous transluminal replacement of aortic valve using biological prosthesis

+∞

7.3

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

7.3

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

+∞

7.3

AR5

Catheter ablation of arrhythmia, target: atrial flutter

+∞

7.3

I20.01

ICD-10 Finland

Unstable angina

2.5

7.3

173

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.5

7.3

N30.0

ICD-10 Finland

Acute cystitis

1.5

7.3

203

1373

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.4

7.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

7.2

503

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

7.2

163

1048

N17

ICPC

Vertigo/dizziness

1.6

7.2

189

1259

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.3

7.2

D07AD01

ATC

clobetasol; topical

1.5

7.2

215

1476

M54

ICD-10 Finland

Dorsalgia

1.6

7.2

150

947

L13

ICPC

Hip symptom/complaint

1.5

7.1

275

1987

-34

ICPC

Blood test

2.6

7.1

151

I45.8

ICD-10 Finland

Other specified conduction disorders

20.1

7.1

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

7.1

102

579

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

7.1

592

4867

E86

ICD-10 Finland

Volume depletion

2.5

7.1

169

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

8.0

7.1

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

7.1

383

2941

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.7

7.1

145

910

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

12.1

7.1

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

7.1

380

2916

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

7.1

428

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

10.1

7.0

A10BX04

ATC

[U] exenatide

4.2

7.0

R13

ICD-10 Finland

Dysphagia

1.8

7.0

110

642

J01MA14

ATC

moxifloxacin; systemic

1.7

7.0

127

772

XQ800

NOMESCO Finland

Prick test

2.0

7.0

401

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

7.0

112

658

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.4

7.0

J01FA15

ATC

telithromycin; oral

1.7

7.0

119

712

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.2

6.9

266

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

6.9

306

E66.0

ICD-10 Finland

Obesity due to excess calories

5.9

6.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

6.9

460

M79.1

ICD-10 Finland

Myalgia

1.6

6.9

180

1198

D07AC01

ATC

betamethasone; topical

1.4

6.9

492

3948

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

6.9

179

1190

A10BJ02

ATC

liraglutide; parenteral

2.6

6.9

148

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

6.9

556

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.1

6.9

314

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

6.8

328

R07.1

ICD-10 Finland

Chest pain on breathing

3.4

6.8

M01AB05

ATC

diclofenac; systemic, rectal

1.3

6.8

918

8062

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

6.8

162

1055

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

6.8

136

848

ZXA05

NOMESCO Finland

Left side

1.4

6.8

344

2610

C07AG02

ATC

carvedilol; oral

1.9

6.8

405

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

6.7

6.8

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.8

6.8

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.8

294

2170

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.8

126

771

B01AC07

ATC

dipyridamole; systemic

1.9

6.8

420

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

6.8

413

Z50.1

ICD-10 Finland

Other physical therapy

1.9

6.8

406

Z51.88

ICD-10 Finland

Other specified medical care

2.7

6.8

132

SFA10

NOMESCO Finland

One-surface restoration

1.3

6.8

706

5985

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

6.7

182

1221

SPAT1101

SPAT

Orthostatic test

2.0

6.7

337

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.0

6.7

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.8

6.7

568

L08

ICPC

Shoulder symptom/complaint

1.4

6.7

312

2334

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.7

477

3825

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

6.7

100

576

M10.0

ICD-10 Finland

Idiopathic gout

2.2

6.6

238

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.3

6.6

206

K24

ICPC

Fear of heart disease

2.5

6.6

163

H26.4

ICD-10 Finland

After-cataract

1.6

6.6

157

1023

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

6.6

312

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

6.6

252

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.6

6.6

134

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

6.6

100

579

EB1MA

NOMESCO Finland

Cephalometry with X-ray

3.4

6.6

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.8

6.5

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

6.9

6.5

E000003, ,

ATC

2.2

6.5

260

A99

ICPC

Disease/condition unspecnature/site

1.6

6.5

149

963

R4110

NOMESCO Finland

Physiotherapy

1.4

6.5

364

2810

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.4

6.5

171

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

6.5

370

SFA20

NOMESCO Finland

Two-surface restoration

1.3

6.5

735

6291

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

6.5

102

597

I95.9

ICD-10 Finland

Hypotension, unspecified

3.2

6.4

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.0

6.4

I27.0

ICD-10 Finland

Primary pulmonary hypertension

70.1

6.4

I44.6

ICD-10 Finland

Other and unspecified fascicular block

70.1

6.4

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

70.1

6.4

C10AX09

ATC

ezetimibe; oral

1.5

6.4

233

1663

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

6.4

121

744

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

6.4

230

1639

J20

ICD-10 Finland

Acute bronchitis

1.7

6.4

128

800

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.8

6.4

DAX08

NOMESCO Finland

Fitting of hearing aid

1.7

6.4

104

615

J01DA09

ATC

[U] cefadroxil

1.4

6.3

332

2532

Z71.8

ICD-10 Finland

Other specified counselling

1.4

6.3

414

3273

QDB10, ,

SPAT

2.4

6.3

167

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

6.3

114

693

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.5

6.3

R51.80

ICD-10 Finland

Headache

1.5

6.3

174

1174

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

6.3

338

2591

342

Kela drug reimbursment

Dronedarone

+∞

6.3

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

+∞

6.3

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

6.3

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

6.3

C01BD07

ATC

dronedarone; oral

+∞

6.3

Catheter ablation of arrhythmia

+∞

6.3

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

6.3

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

6.3

AC4

MVP

+∞

6.3

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

+∞

6.3

B82

ICPC

Anaemia other/unspecified

2.3

6.2

212

A29

ICPC

General symptom/complaint other

1.5

6.2

187

1284

Q21.10

ICD-10 Finland

Persistent ostium secundum

26.8

6.2

M25.5

ICD-10 Finland

Pain in joint

1.4

6.2

400

3152

C07AA05

ATC

propranolol; systemic

1.5

6.2

213

1503

SPAT1251

SPAT

Organisation of medication

2.3

6.2

187

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

6.2

252

SPAT1266

SPAT

Separate instruction to prepare for procedure

2.4

6.2

181

L01

ICPC

Neck symptom/complaint

1.5

6.2

195

1353

Coronary artery bypass surgery

2.7

6.2

121

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

6.2

221

1574

S76

ICPC

Skin infection other

1.9

6.2

391

R12

ICD-10 Finland

Heartburn

1.7

6.1

106

637

R52.9

ICD-10 Finland

Pain, unspecified

1.6

6.1

135

865

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

12.6

6.1

A01AB09

ATC

miconazole; local oral

1.7

6.1

116

716

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

6.1

158

1052

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.8

6.0

503

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

6.0

518

C09BA02

ATC

enalapril and diuretics; systemic

1.7

6.0

115

710

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

887

3270

4.76

214.47

4.4

1.9

1374.35

559.13

ng/l

11.41

771

2654

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

922

4707

3.21

115.74

6.0

2.9

42.96

60.76

ng/l

0.64

750

3444

(3032080) INR in Blood by Coagulation assay

1008

5729

2.99

98.96

20.9

6.0

1.35

1.09

inr

35.65

880

4641

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

409

1671

2.93

70.15

3.0

2.1

21.30

23.81

3.15

381

1544

(3004789) Transferrin [Mass/volume] in Serum or Plasma

434

1833

2.86

69.97

3.1

2.1

2.29

2.27

g/l

0.31

403

1671

(3022948) Iron [Moles/volume] in Serum or Plasma

455

1979

2.80

69.30

3.2

2.2

12.17

13.37

umol/l

2.94

421

1822

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

224

701

3.55

59.52

3.6

3.1

2.09

1.51

mmol/l

1.13

166

500

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

247

830

3.33

58.62

4.0

3.2

5.20

5.11

kpa

0.70

242

792

(3009343) pH of Capillary blood

242

808

3.34

58.00

4.0

3.2

7.41

7.42

0.42

212

659

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1022

6852

2.32

56.93

10.0

6.3

1.21

mmol/l

0.40

863

5856

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

930

6090

2.23

53.51

9.2

5.6

1.21

mmol/l

0.06

837

5560

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

494

2525

2.37

51.50

2.0

1.6

1.24

1.45

mg/l

1.00

381

1997

(42870588) Differential panel, method unspecified - Blood

722

4320

2.21

51.49

8.0

5.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

998

6885

2.16

48.21

7.4

6.9

11.71

12.03

umol/l

0.31

956

6539

(3013826) Glucose [Moles/volume] in Serum or Plasma

1080

7690

2.20

48.01

8.0

4.3

6.97

6.76

mmol/l

2.01

1043

7258

(3006504) Eosinophils/Leukocytes in Blood

893

5950

2.11

46.68

8.5

6.2

2.90

2.93

0.15

832

5493

(3022096) Basophils/Leukocytes in Blood

893

5959

2.10

46.38

8.6

6.3

0.67

0.12

829

5495

(3019069) Monocytes/Leukocytes in Blood

893

5960

2.10

46.35

8.6

6.3

9.12

9.07

0.22

829

5506

(3018010) Neutrophils/Leukocytes in Blood

887

5949

2.08

44.91

8.3

6.1

58.94

57.43

3.75

842

5621

(3002030) Lymphocytes/Leukocytes in Blood

899

6082

2.07

44.18

8.5

6.2

25.76

27.38

5.04

851

5693

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

581

3349

2.14

43.92

3.0

2.1

3.04

2.75

mg/l

1.75

500

2820

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

418

2110

2.32

43.87

2.1

1.8

—

(3006315) Basophils [#/volume] in Blood

934

6436

2.06

43.29

8.0

5.9

0.04

e9/l

0.03

800

5387

(3001604) Monocytes [#/volume] in Blood

931

6414

2.05

43.10

8.0

5.9

0.63

0.60

e9/l

2.40

799

5359

(3022313) Gas panel - Capillary blood

177

582

3.29

43.02

3.8

3.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

653

3959

2.08

42.97

2.7

2.1

215.75

215.22

u/l

0.00

615

3729

(3019198) Lymphocytes [#/volume] in Blood

947

6569

2.05

42.96

8.1

6.0

1.77

1.94

e9/l

3.26

824

5651

(3013115) Eosinophils [#/volume] in Blood

954

6648

2.05

42.58

8.2

6.1

0.20

e9/l

0.10

821

5653

(3019225) pH of Specimen

305

1361

2.53

41.96

4.7

4.0

7.37

7.35

0.41

219

937

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

150

453

3.55

41.66

3.6

3.5

24.93

24.66

mmol/l

0.50

138

414

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

222

866

2.81

39.87

2.4

1.9

7.70

6.15

ug/l

0.41

180

729

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

354

1731

2.34

39.56

5.9

5.1

32.23

32.74

0.34

259

1043

(3001122) Ferritin [Mass/volume] in Serum or Plasma

803

5380

1.97

38.72

4.1

2.7

144.29

152.58

ug/l

0.35

739

4927

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

204

775

2.87

38.44

3.7

1.8

257.96

85.15

ng/l

5.33

184

682

(3023368) Bacteria identified in Blood by Culture

613

3764

2.01

37.79

5.2

3.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1280

10159

2.21

37.67

10.5

8.1

78.32

81.97

u/l

1.58

1218

9545

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1217

9507

2.11

36.82

6.0

4.1

14.29

12.13

mm/h

4.14

1114

8758

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

413

2251

2.12

34.80

5.5

2.9

311.50

509.73

ng/l

0.95

343

1790

(3027945) Reticulocytes/Erythrocytes in Blood

313

1553

2.26

33.27

3.0

2.4

1.76

1.70

0.61

266

1361

(3037467) Urinalysis macro (dipstick) panel - Urine

1158

9035

1.97

33.05

5.7

4.4

—

2.71

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

883

6338

1.86

32.32

2.6

2.1

101.42

94.06

pmol/l

4.04

522

3391

(3013650) Neutrophils [#/volume] in Blood by Automated count

986

7327

1.88

32.31

11.3

9.7

4.40

4.20

e9/l

1.13

847

6270

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

100

274

3.82

31.96

3.4

2.3

0.33

iu/ml

0.08

128

(3020779) Urea [Moles/volume] in Serum or Plasma

237

1064

2.44

31.61

7.6

5.4

11.20

9.07

mmol/l

3.52

225

1012

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1371

11451

2.25

31.41

6.4

4.8

1.97

1.98

mu/l

0.05

1233

10305

(3003458) Phosphate [Moles/volume] in Serum or Plasma

313

1597

2.19

30.86

6.6

4.8

1.05

1.00

mmol/l

2.14

292

1487

(3012095) Magnesium [Moles/volume] in Serum or Plasma

365

1978

2.09

30.78

4.1

3.2

0.81

0.82

mmol/l

0.52

341

1848

(3044640) Blood type and Crossmatch panel - Blood

645

4272

1.84

29.89

2.8

2.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1109

8680

1.87

29.43

6.1

4.6

239.25

1884.39

e6/l

1.47

150

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

293

1484

2.19

29.31

4.1

4.4

241.38

237.74

u/l

0.15

273

1404

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

628

4166

1.83

28.65

3.2

2.5

55.71

61.88

u/l

2.40

579

3833

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1449

12514

2.43

28.50

26.5

14.5

24.01

27.54

mg/l

3.27

1270

10184

(3021960) Folate [Moles/volume] in Serum or Plasma

624

4139

1.82

28.42

2.0

1.6

20.94

20.28

nmol/l

0.30

512

3441

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1161

9269

1.88

28.32

5.1

3.9

15.22

14.86

pmol/l

4.53

1033

8279

(3024561) Albumin [Mass/volume] in Serum or Plasma

841

6116

1.78

27.87

5.6

4.7

34.72

35.50

g/l

3.50

790

5677

(3003396) Base excess in Arterial blood by calculation

274

1387

2.17

27.31

11.6

7.0

1.33

0.67

mmol/l

1.53

229

1132

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

804

5812

1.76

26.84

2.7

2.3

78.96

78.73

nmol/l

0.08

701

5119

(3023520) Reticulocytes [#/volume] in Blood

244

1195

2.23

26.34

2.6

2.4

67.43

65.76

e9/l

0.36

191

864

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

136

512

2.81

25.81

2.1

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

417

2500

1.90

25.76

1.9

1.7

1109.20

1136.14

nmol/l

0.21

305

1873

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

127

463

2.89

25.58

3.4

1.6

38.14

39.81

u/l

0.36

106

407

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

507

3239

1.82

25.55

2.7

2.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

269

1409

2.09

24.35

11.8

6.9

11.14

12.58

kpa

6.20

260

1357

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

269

1409

2.09

24.35

11.8

6.9

5.16

5.10

kpa

0.45

260

1356

(3018677) aPTT in Platelet poor plasma by Coagulation assay

320

1792

1.98

24.04

2.6

1.8

30.20

28.65

4.75

314

1746

(3019977) pH of Arterial blood

267

1406

2.08

23.79

11.9

7.0

7.41

7.42

0.09

156

760

(3015235) Bicarbonate [Moles/volume] in Capillary blood

119

437

2.86

23.63

3.8

2.4

25.09

24.73

mmol/l

0.36

119

431

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1359

11678

1.99

23.33

5.3

4.2

1.31

1.29

mmol/l

0.35

1228

10474

(3007853) Bacteria identified in Skin by Aerobe culture

266

1410

2.06

23.24

2.0

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

179

809

2.36

23.24

1.8

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1479

13147

2.36

22.76

32.6

17.0

139.53

139.68

mmol/l

1.34

1457

12810

(3023103) Potassium [Moles/volume] in Serum or Plasma

1479

13168

2.34

22.31

32.8

17.2

4.02

3.99

mmol/l

5.79

1454

12806

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

125

488

2.69

22.09

2.0

1.7

—

(3016502) Oxygen saturation in Arterial blood

240

1253

2.07

21.77

12.7

7.4

94.76

95.91

1.75

231

1210

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1012

8050

1.68

21.75

4.4

3.2

54.62

52.42

u/l

0.28

925

7441

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

282

1568

1.97

21.43

1.9

1.7

—

(3042936) Bacteria identified in Isolate by Culture

304

1739

1.92

21.22

2.3

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

498

3315

1.72

21.01

3.4

2.6

362.23

343.42

umol/l

3.36

429

2889

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1394

12229

1.97

20.42

25.0

14.7

74.96

78.02

ml/min/173m2

6.26

1305

11288

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

802

6090

1.62

20.04

3.1

2.7

—

estimate

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

112

435

2.69

19.98

3.4

2.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1481

13330

2.22

19.44

16.5

11.7

25.47

26.19

u/l

0.82

1431

12830

(40761511) CBC panel - Blood by Automated count

1441

12844

2.06

19.32

23.5

13.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1373

12057

1.88

19.01

8.8

6.7

41.33

39.57

mmol/mol

8.71

1253

11101

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

157

733

2.26

18.81

15.8

8.2

24.57

24.19

mmol/l

0.61

151

720

(3020630) Protein [Mass/volume] in Serum or Plasma

213

1122

2.03

18.72

2.5

2.7

65.61

66.88

g/l

1.40

197

1013

(3020682) Albumin/Creatinine [Ratio] in Urine

656

4801

1.61

18.65

4.8

4.1

12.83

5.74

mg/mmol

2.24

410

2971

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1397

12372

1.91

18.32

6.2

5.1

4.30

4.57

mmol/l

18.02

1272

11331

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1492

13529

2.22

18.21

34.3

19.5

86.67

79.49

umol/l

8.93

1471

13306

(3037522) Nuclear Ab [Titer] in Serum

260

1481

1.90

18.18

1.3

543.23

487.10

titre

0.21

321

(3012516) Albumin [Mass/volume] in Urine

643

4707

1.60

18.12

4.0

3.4

69.60

33.66

mg/l

2.70

405

2968

(40768797) Stomach Pathology biopsy report

302

1812

1.82

17.89

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1386

12278

1.86

17.68

6.3

5.0

1.38

1.44

mmol/l

7.23

1254

11149

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

129

570

2.37

17.55

1.5

1.55

g/l

0.02

107

496

(3009508) Creatinine [Moles/volume] in Urine

658

4875

1.59

17.44

3.9

3.4

7.15

7.80

mmol/l

3.46

512

4054

(3015377) Calcium [Moles/volume] in Serum or Plasma

646

4775

1.58

17.24

3.5

3.6

2.35

2.36

mmol/l

0.38

554

4294

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

185

956

2.05

17.08

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1388

12338

1.84

17.00

6.7

5.3

6.23

6.01

mmol/l

5.28

1248

11122

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1413

12637

1.89

16.87

7.0

5.9

2.45

2.66

mmol/l

14.91

1281

11539

(3006184) Hemoglobin [Mass/volume] in Capillary blood

297

2.85

16.71

2.9

1.9

127.52

129.75

g/l

0.31

223

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

571

4127

1.59

16.62

3.8

3.3

33.69

38.53

u/l

0.55

538

3875

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

829

6521

1.55

16.61

3.0

2.6

—

(3025159) Blasts/Leukocytes in Blood

208

1137

1.95

16.37

4.4

4.8

0.00

0.10

3.36

295

(3002173) Hemoglobin [Mass/volume] in Arterial blood

215

1189

1.93

16.35

13.8

7.7

121.43

121.79

g/l

0.09

210

1159

(3004588) Protein electrophoresis panel - Serum or Plasma

179

931

2.04

16.22

2.5

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

180

941

2.03

16.08

4.5

3.2

91.62

81.00

ng/l

0.76

144

812

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

155

769

2.12

15.92

17.3

7.4

25.11

24.72

mmol/l

0.57

155

762

(3012544) pH of Venous blood

220

1237

1.90

15.90

6.7

3.0

7.38

0.31

139

713

(3021440) Promyelocytes/Leukocytes in Blood

206

1134

1.93

15.86

4.3

4.6

0.03

0.13

2.41

319

(3017181) Myelocytes/Leukocytes in Blood

213

1188

1.91

15.77

4.3

4.5

0.54

0.92

2.17

371

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

118

528

2.33

15.59

2.0

1.7

2.98

2.13

ug/l

0.33

109

468

(1616796) Gas panel - Central venous blood

249

2.94

15.35

4.5

3.2

—

(3015736) pH of Urine

719

5548

1.53

15.28

3.9

3.3

6.24

0.02

391

3053

(3009261) Glucose [Presence] in Urine by Test strip

877

7063

1.52

15.23

4.9

3.8

0.05

0.01

estimate

0.70

181

1385

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

249

1480

1.81

15.04

2.7

12.09

9.92

umol/l

0.47

223

1331

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

170

892

2.01

15.01

1.8

1.6

—

(3002179) Metamyelocytes/Leukocytes in Blood

200

1110

1.91

15.00

4.1

4.5

0.57

0.63

0.18

330

(3002032) Base excess in Venous blood by calculation

212

1200

1.88

14.97

6.8

3.0

1.79

1.80

mmol/l

0.01

184

1019

(3014111) Lactate [Moles/volume] in Serum or Plasma

202

1126

1.91

14.95

15.5

6.4

1.25

1.33

mmol/l

0.81

196

1100

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1495

13735

2.08

14.91

39.0

22.5

91.69

91.45

1.14

1480

13493

(3026361) Erythrocytes [#/volume] in Blood

1495

13735

2.08

14.91

39.1

22.5

4.44

4.48

e12/l

1.79

1458

13274

(3035941) MCH [Entitic mass]

1495

13735

2.08

14.91

39.0

22.5

30.40

30.48

0.91

1480

13492

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1495

13736

2.07

14.89

40.6

22.9

39.99

40.30

1.20

1480

13486

(3010813) Leukocytes [#/volume] in Blood

1495

13737

2.07

14.87

39.3

22.6

7.08

6.79

e9/l

3.24

1460

13269

(3000963) Hemoglobin [Mass/volume] in Blood

1495

13739

2.07

14.83

39.5

22.7

133.81

135.54

g/l

3.93

1481

13501

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

134

646

2.17

14.80

1.7

1.4

—

(3007461) Platelets [#/volume] in Blood

1494

13732

2.06

14.73

39.3

22.6

240.93

245.83

e9/l

2.08

1464

13320

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

245

1459

1.80

14.68

2.0

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

869

7017

1.51

14.68

4.7

3.7

12.44

4.58

estimate

0.41

207

1494

(3000850) Epithelial cells [#/volume] in Urine

446

3116

1.59

14.64

3.5

2.5

4.90

4.81

e6/l

0.05

405

2815

(3018095) Leukocytes [#/volume] in Urine

661

5053

1.52

14.43

5.2

3.9

81.43

95.83

e6/l

0.30

498

3580

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

174

3.24

14.18

2.2

1.8

16.44

22.36

mg/l

0.74

(3036481) Cortisol [Moles/volume] in Serum or Plasma

190

1058

1.90

14.08

2.7

2.3

338.41

378.79

nmol/l

1.94

177

971

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

5.75

13.69

5.3

2.0

677.16

1438.89

u/ml

0.79

(3030467) Casts [#/volume] in Urine by Automated count

526

3868

1.53

13.57

4.5

3.3

0.54

0.45

e6/l

0.43

408

2816

(3017732) Neutrophils [#/volume] in Blood

254

1565

1.74

13.47

3.4

5.17

4.80

e9/l

0.15

198

1313

(3021601) Nitrite [Presence] in Urine by Test strip

853

6941

1.48

13.35

4.8

3.7

0.00

estimate

-0.00

201

1455

(3007164) IgA [Mass/volume] in Serum or Plasma

339

2263

1.63

13.26

1.9

1.5

2.68

2.57

g/l

0.32

219

1332

(3018418) pH of Serum or Plasma

551

4110

1.51

13.23

4.9

3.7

7.40

0.39

417

2928

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

424

2.34

13.08

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

167

917

1.91

12.89

3.5

2.7

10.54

10.81

g/l

0.23

161

837

(3021447) Carbon dioxide [Partial pressure] in Venous blood

211

1249

1.79

12.83

6.9

3.0

5.88

5.74

kpa

1.24

204

1223

(3000991) Gas panel - Venous blood

186

1064

1.84

12.64

18.5

7.2

—

(3026782) Osmolality of Urine

388

2703

1.57

12.62

3.8

2.8

516.73

558.79

mosm/kgh2o

3.61

341

2336

(3002582) Erythrocytes [#/volume] in Urine

593

4525

1.49

12.60

4.5

3.3

43.72

84.92

e6/l

1.58

477

3456

(40768804) Tissue Pathology biopsy report

671

5254

1.47

12.49

2.3

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

552

2.15

12.46

2.7

2.3

7.37

7.41

g/l

0.08

108

494

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

552

2.15

12.46

2.7

2.3

4.13

4.19

g/l

0.34

108

495

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

552

2.15

12.46

2.7

2.3

3.53

3.79

g/l

1.27

108

494

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

217

1306

1.76

12.45

2.8

2.2

0.21

g/l

0.46

204

1232

(3005322) IgE [Units/volume] in Serum or Plasma

127

644

2.05

12.30

1.6

1.3

427.97

291.64

u/ml

0.33

118

605

(3009445) Proteinase 3 Ab [Units/volume] in Serum

103

484

2.20

12.13

1.3

1.6

—

14.35

—

(3026008) Bacteria identified in Urine by Culture

535

4061

1.47

11.42

3.8

3.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

433

2.22

11.22

3.1

3.5

64.00

166.52

mg/l

0.39

373

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

433

2.22

11.22

3.1

3.5

38.36

73.23

mg/l

0.70

374

(4146454) Self-monitoring of blood glucose

167

2.99

11.20

2.6

—

(3010421) pH of Blood

371

2.30

11.03

4.4

3.2

7.40

7.41

0.35

365

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

112

567

2.05

10.90

4.1

3.4

4.35

4.54

pmol/l

1.41

501

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

361

2.31

10.84

1.1

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

133

718

1.93

10.79

3.2

2.1

1.69

1.53

g/l

0.19

128

656

(3048689) Calprotectin [Mass/mass] in Stool

227

1444

1.66

10.58

2.3

134.46

147.10

ug/g

0.24

182

1149

(3014576) Chloride [Moles/volume] in Serum or Plasma

265

1755

1.61

10.52

13.7

6.2

104.30

104.29

mmol/l

0.01

265

1755

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

409

2987

1.49

10.43

1.9

1.7

16199799.59

34085831.02

pmol/l

0.46

321

2482

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

215

1354

1.68

10.41

3.8

3.1

—

(3037121) Protein [Mass/volume] in Urine

434

2.16

10.36

3.0

3.5

313.39

247.13

mg/l

0.47

186

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

141

790

1.86

10.21

18.0

8.5

0.60

0.66

1.04

141

784

(3000492) Spirometry study

182

1101

1.74

10.20

1.7

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

444

3320

1.46

9.99

5.2

3.8

82.33

92.00

12.48

439

3254

(3008152) Bicarbonate [Moles/volume] in Arterial blood

130

719

1.88

9.81

7.6

6.5

25.25

24.33

mmol/l

1.54

125

685

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

159

2.88

9.69

1.1

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

234

2.53

9.68

1.3

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

188

2.71

9.60

1.3

1.6

—

(3021589) Normoblasts [#/volume] in Blood

695

5672

1.39

9.47

17.7

10.3

0.00

e9/l

0.12

575

4587

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

141

809

1.81

9.47

17.3

8.3

1.31

1.27

0.17

141

802

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

383

2.17

9.44

3.2

3.5

2.05

3.21

ratio

0.57

221

(3028271) Lactate [Moles/volume] in Capillary blood

167

2.81

9.43

2.5

1.6

1.82

1.72

mmol/l

0.26

161

(3029937) Albumin [Presence] in Urine by Test strip

513

3976

1.42

9.42

4.6

3.7

0.00

estimate

0.69

182

1339

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

293

2.34

9.40

1.4

1.14

1.21

g/l

0.93

273

(3000494) Fungus identified in Specimen by Culture

234

1544

1.60

9.38

1.6

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

136

775

1.82

9.34

6.9

2.7

128.73

128.57

g/l

0.03

130

750

(3022145) Colonoscopy Study observation

224

1466

1.61

9.28

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

140

808

1.80

9.22

18.4

8.4

94.52

94.39

0.16

140

803

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

511

2.00

9.16

2.9

2.3

3.03

2.93

g/l

0.46

454

(3045414) Leukocytes [Presence] in Urine

198

1264

1.64

9.06

2.3

2.1

0.00

0.01

estimate

0.50

263

(3000093) Morphology [Interpretation] in Blood Narrative

112

3.17

8.94

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

289

2.30

8.80

1.8

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

356

2608

1.47

8.75

1.4

1.2

3.19

1.50

u/ml

0.61

671

(3024522) Salmonella sp identified in Specimen by Organism specific culture

157

2.79

8.75

1.1

1.4

—

(3042631) Mycobacterium sp identified in Specimen

186

2.63

8.71

2.7

2.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

494

1.98

8.62

2.6

2.4

10.23

10.34

g/l

0.09

432

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

495

1.98

8.57

3.2

2.5

0.45

1.44

g/l

2.54

415

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

296

2102

1.50

8.48

1.3

32.22

37.87

iu/ml

0.36

624

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

277

2.29

8.31

1.4

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

221

2.45

8.29

5.3

3.9

8.16

8.49

kpa

0.71

214

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

156

2.74

8.29

1.1

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

279

1973

1.50

8.13

1.3

8.17

15.75

u/ml

1.34

706

(3024928) Oxygen saturation in Venous blood

267

2.29

8.13

10.9

3.1

62.89

58.67

0.79

260

(40760888) Immunoglobulin light chains.free panel - Serum

283

2.24

7.92

2.9

3.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

221

2.40

7.82

5.2

3.9

5.16

4.98

kpa

0.77

215

(3006462) Nitrate [Presence] in Urine

3.81

7.81

5.4

4.0

—

(4035726) Immunohistochemistry procedure

186

1217

1.60

7.68

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

224

2.37

7.60

1.6

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

224

2.37

7.60

1.6

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

309

2263

1.45

7.51

3.8

3.2

3.36

1.99

e6/l

1.18

159

1121

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

419

1.98

7.49

2.8

2.5

0.00

0.05

g/l

1.26

370

(3023199) Leukocytes [#/volume] in Pleural fluid

109

2.97

7.41

1.8

1.2

1790.73

10803.03

e6/l

0.58

(3024980) IgG subclass 4 [Mass/volume] in Serum

190

2.46

7.37

1.2

1.7

0.80

0.89

g/l

0.21

149

(3012501) Base excess in Blood by calculation

221

2.35

7.37

5.2

3.9

2.88

2.23

mmol/l

0.74

143

(40768806) Pleura Pathology biopsy report

3.07

7.33

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.09

7.18

5.2

3.2

—

(3045424) Erythrocytes [Presence] in Urine

113

663

1.76

7.07

2.0

2.1

0.00

0.02

estimate

0.68

206

(3000570) Elastase.pancreatic [Mass/mass] in Stool

400

1.97

7.05

1.5

1.4

250.79

276.01

ug/g

0.52

239

(3023419) Bacteria identified in Sputum by Culture

188

2.43

7.05

2.6

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

176

2.48

7.04

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

278

2.16

7.01

1.4

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

167

1089

1.59

7.00

5.0

3.6

1.22

1.23

mmol/l

0.60

147

928

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

327

2449

1.42

6.99

3.8

3.1

1.15

1.14

e6/l

0.01

178

1311

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

154

2.57

6.88

1.1

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

350

2661

1.40

6.86

6.4

4.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

274

2.16

6.85

1.7

1.4

—

(4211845) Urine protein measurement

3.47

6.85

5.4

3.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

155

2.55

6.79

1.1

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

357

2.00

6.77

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

156

2.54

6.71

1.1

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

114

682

1.72

6.67

2.6

2.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

738

6311

1.31

6.57

6.1

4.65

3.83

ug/l

0.18

645

5724

(40768443) Skin Pathology biopsy report

558

1.79

6.51

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

412

1.91

6.49

2.8

2.5

0.00

g/l

-0.00

354

(4015189) Microbial culture of sputum

6.20

6.47

2.5

2.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

236

2.20

6.36

1.1

1.3

29.37

28.82

u/l

0.02

196

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.60

6.32

1.3

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.60

6.32

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.60

6.32

1.3

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.60

6.32

1.3

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

131

2.63

6.32

3.4

4.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

132

834

1.63

6.30

2.4

2.5

33.04

18.20

au/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

232

2.19

6.20

1.3

1.4

—

(3004451) EKG impression Narrative

3.54

6.16

1.8

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

145

2.52

6.13

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

182

2.34

6.11

1.1

1.61

1.53

g/l

0.64

163

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

409

1.87

5.99

1.5

1.6

8.79

17.79

u/ml

1.88

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

106

2.77

5.97

1.3

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

582

1.73

5.91

3.9

2.5

25.13

25.06

mmol/l

0.07

559

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

124

2.61

5.90

1.8

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

312

1.99

5.89

1.3

1.2

1.96

7.22

u/ml

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

136

2.53

5.88

1.4

56.24

58.48

0.11

(46235355) HIV 1 and 2 tests - Meaningful Use set

225

1622

1.45

5.88

1.9

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

149

2.45

5.81

3.9

4.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

314

1.98

5.79

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

357

1.91

5.75

2.9

3.2

1.72

1.44

mg/l

2.14

323

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

156

2.40

5.74

1.1

1.0

—

(3035715) Granulocytes [#/volume] in Blood

201

2.22

5.69

3.0

4.09

4.14

e9/l

0.07

201

(3017143) Hepatitis C virus Ab [Presence] in Serum

168

1151

1.51

5.66

1.8

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

115

2.64

5.66

1.3

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

134

2.49

5.55

1.4

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.84

5.54

1.2

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.84

5.54

1.2

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.63

5.48

1.1

1.2

106.45

70.16

mg/l

0.84

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

300

1.97

5.45

1.5

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

205

2.18

5.44

3.4

2.7

15.42

8.99

pmol/l

1.49

205

(3000475) Leukocytes [#/volume] in Synovial fluid

336

1.91

5.41

1.6

26904.40

14388.60

e6/l

0.54

227

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

119

762

1.61

5.41

1.4

1.3

49.72

64.17

au/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

323

1.92

5.36

2.9

3.1

5.66

2.75

index

0.32

160

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

196

1401

1.45

5.35

1.6

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

628

5360

1.28

5.33

2.0

1.9

1.35

1.34

mmol/l

0.06

485

4440

(3014051) Protein [Presence] in Urine by Test strip

439

3579

1.31

5.30

3.8

3.0

0.00

0.04

0.80

106

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

325

1.91

5.27

1.2

48.80

15.50

u/ml

—

(3016750) Collection duration of Urine

3.00

5.26

1.9

500.25

494.36

min

0.13

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

2.18

5.25

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

406

1.81

5.21

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

313

1.92

5.16

1.2

2.37

2.67

u/ml

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

139

2.40

5.16

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.74

5.11

1.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.74

5.11

1.2

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.74

5.11

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

104

2.62

5.07

2.3

2.1

714.05

660.74

0.30

(3024139) IgG subclass 3 [Mass/volume] in Serum

116

2.53

5.05

1.1

1.2

0.43

0.39

g/l

0.22

(3028192) IgG subclass 2 [Mass/volume] in Serum

116

2.53

5.05

1.1

1.2

2.51

3.19

g/l

1.71

(3027135) IgG subclass 1 [Mass/volume] in Serum

116

2.53

5.05

1.1

1.2

7.40

6.79

g/l

0.34

(21494890) Protein electrophoresis panel - 24 hour Urine

111

2.55

4.97

2.0

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

445

3662

1.30

4.96

4.5

3.3

0.02

0.01

estimate

0.20

159

1163

(3035933) Granulocytes/Leukocytes in Blood

241

2.02

4.92

3.7

2.9

59.60

58.19

0.41

241

(36660697) Celiac disease serology panel - Serum

133

894

1.53

4.92

1.2

—

(3037756) Immunofixation for Serum or Plasma

290

1.93

4.92

1.3

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

459

1.73

4.91

1.4

1.6

1.74

6.33

iu/ml

3.51

108

(4062490) Immunoglobulin typing, IgG

112

2.53

4.89

1.6

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

4.58

4.87

6.7

1.2

21.33

287.37

ug/l

0.50

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

279

1.93

4.77

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.60

4.77

1.2

1.5

—

(3025941) Bacteria identified in Stool by Culture

565

1.65

4.71

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

117

772

1.56

4.71

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

165

2.21

4.67

1.3

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

103

2.55

4.64

1.9

1.2

36210.41

95546.79

e6/l

1.03

(3000012) Reticulocyte production index

187

2.11

4.54

2.4

2.2

0.85

0.87

0.04

130

(3003181) Sodium [Moles/volume] in Urine

222

2.01

4.48

1.4

1.3

53.26

62.10

mmol/l

0.85

181

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

259

1.92

4.38

1.2

1.1

3.13

3.41

—

(3049717) Cytology report of Urine Cyto stain

633

1.58

4.34

3.1

3.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

2.41

4.32

2.6

2.2

1.45

1.95

u/field

0.20

(40768795) Lymph node Pathology biopsy report

113

2.41

4.32

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

297

1.85

4.29

7.7

2.2

3.34

3.59

g/l

0.86

285

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

602

5221

1.24

4.20

5.2

3.7

0.01

0.02

estimate

0.42

168

1197

(40762814) Titanium [Mass/volume] in Blood

4.83

4.18

2.8

2.3

2.74

2.71

ug/l

—

(3020491) Glucose [Moles/volume] in Blood

2.50

4.14

2.1

1.8

9.33

6.52

mmol/l

1.16

(3020876) Protein [Mass/time] in 24 hour Urine

141

2.22

4.13

1.9

2.5

1.13

1.41

g/24h

0.22

(40761536) Microorganisms panel - Urine sediment

143

1014

1.45

4.10

5.4

3.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

346

1.76

4.10

1.5

0.42

0.13

iu/ml

—

(3017569) Oxygen content in Arterial blood

2.77

4.02

2.2

2.7

17.17

16.83

0.12

(3045788) Cell count panel - Pleural fluid

2.55

3.97

2.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

199

1.98

3.89

1.3

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

351

2883

1.28

3.87

3.3

3.1

2.47

2.45

mmol/l

1.74

318

2598

(3035637) Corticotropin [Mass/volume] in Plasma

153

2.11

3.79

1.5

40.25

27.48

ng/l

0.29

153

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

210

1613

1.35

3.77

4.1

4.7

44.96

29.17

ug/l

0.17

179

1346

(40762887) Creatinine [Moles/volume] in Blood

8.78

3.77

1.9

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

325

1.75

3.77

2.4

2.2

169.03

102.39

ug/min

0.40

189

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

586

1.55

3.67

5.2

5.0

1.58

1.48

0.51

557

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.49

3.63

1.1

1.2

96.19

112.08

pmol/l

0.73

(3013139) Helicobacter pylori Ag [Presence] in Stool

122

862

1.45

3.59

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

373

1.66

3.43

1.7

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.77

3.39

2.7

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.63

3.30

2.8

2.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.63

3.30

2.5

1.8

2.00

5.35

u/field

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

176

1.95

3.30

1.4

2.3

3.78

4658.30

u/l

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

529

1.54

3.27

5.6

5.2

0.89

0.88

0.05

500

(3012441) Differential panel - Pleural fluid

2.31

3.27

1.8

1.3

—

(3022621) pH of Urine by Test strip

140

1035

1.39

3.22

4.1

2.8

6.16

6.06

0.62

714

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.87

3.19

1.1

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.87

3.19

1.1

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.35

3.19

2.6

1.5

40.88

50.20

umol/l

—

(3036489) Thrombin time

397

1.61

3.17

4.1

1.8

21.23

20.20

1.64

362

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.30

3.10

1.8

735.14

707.57

0.02

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.30

2.99

1.0

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

162

1.93

2.96

1.3

1.1

—

4.17

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.29

2.94

1.5

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

773

0.61

2.94

1.6

1.8

3.64

3.48

mmol/l

0.44

562

(3047181) Lactate [Moles/volume] in Blood

351

1.62

2.90

6.3

6.6

1.49

1.36

mmol/l

0.63

304

(3025549) Creatine [Moles/time] in 24 hour Urine

6.69

2.87

2.0

1.4

—

(3002256) Pathology report gross observation

234

1896

1.27

2.86

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

377

3225

1.22

2.83

4.6

3.6

0.00

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

238

1.74

2.83

4.7

4.9

236.71

7640.52

iu/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.66

2.79

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.48

2.79

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

8.35

2.75

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1045

0.67

2.75

1.9

2.1

3.91

3.54

ratio

1.21

837

(3000330) Specific gravity of Urine by Test strip

702

1.42

2.74

4.7

3.6

1.02

ratio

2.67

640

(3023323) Follitropin [Units/volume] in Serum or Plasma

287

1.66

2.71

1.4

1.5

24.21

24.37

iu/l

0.01

242

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

3.01

2.69

1.0

—

5.36

—

(4024509) Urine culture

637

1.44

2.69

2.2

1.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

204

1640

1.28

2.67

9.4

6.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

281

1.66

2.66

1.7

1.6

0.98

0.80

nmol/l

0.86

238

(3010144) Erythrocytes [#/volume] in Synovial fluid

133

1.97

2.66

1.5

1.3

247613.53

106737.92

e6/l

0.30

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

162

1.87

2.63

1.1

3.45

1.66

u/ml

0.35

(21494434) Karyotype in Bone marrow

120

2.01

2.61

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

141

1.93

2.61

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

107

2.07

2.57

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

114

2.03

2.56

3.0

3.1

23.29

11.06

index

1.34

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.37

2.56

1.1

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.74

2.55

1.6

1.5

38.33

40.55

g/l

0.49

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.43

2.54

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.24

2.52

1.1

1.7

—

(3008295) Osmolality of Serum or Plasma

129

1.95

2.51

1.3

1.4

284.94

278.95

mosm/kgh2o

0.59

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

318

1.59

2.48

1.4

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.33

2.48

1.1

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.82

2.46

2.5

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

130

1.94

2.46

1.3

1.1

—

(3048879) Bone marrow aspiration report

3.14

2.43

1.1

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

297

1.60

2.41

1.4

10.19

8.94

u/l

0.31

247

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.01

2.40

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

160

1.83

2.40

1.2

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

2.22

2.37

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.43

2.37

5.2

3.4

187.43

189.34

u/l

0.06

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

154

1214

1.30

2.36

3.2

2.4

40.07

39.57

u/l

0.03

133

1027

(40758558) Short blood count panel - Blood

437

3851

1.18

2.35

8.4

6.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

237

1.66

2.33

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.32

2.31

1.1

10.63

9.08

iu/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.13

2.29

1.2

0.05

1.66

u/ml

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

262

1.62

2.28

1.5

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.56

2.27

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.03

2.26

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.16

2.25

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

149

1.83

2.25

1.4

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

432

3819

1.18

2.23

3.5

3.4

0.77

0.83

ug/l

0.84

308

2637

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.11

2.22

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

157

1.80

2.22

3.0

1.9

1.18

1.19

mmol/l

0.12

157

(3014891) Appearance of Pleural fluid

5.57

2.21

2.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

196

1607

1.25

2.20

1.6

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

2.19

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.34

2.18

1.1

1.2

—

0.73

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.34

2.18

2.5

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

115

1.93

2.16

1.4

1.2

—

(3014271) Vancomycin [Susceptibility]

2.17

2.15

2.8

2.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.63

2.14

1.4

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

159

1.77

2.14

3.0

1.9

106.36

105.13

mmol/l

0.49

159

(3041354) Potassium [Moles/volume] in Venous blood

159

1.77

2.14

3.0

1.9

4.01

4.07

mmol/l

0.32

159

(40765096) Chromosome analysis panel by Banding

2.57

2.08

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.01

2.07

1.4

1.0

86.40

101.90

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

110

1.92

2.06

1.6

1.4

17.80

30.77

u/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

169

1376

1.25

2.03

1.8

1.57

1.55

0.09

141

1194

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

162

1.74

2.02

1.3

0.63

11.59

nmol/l

0.50

155

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

673

1.36

2.02

1.2

69.65

119.84

u/ml

1.02

245

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.06

2.01

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.06

2.01

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.06

2.01

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.64

2.00

4.9

2.4

11.67

10.45

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.64

2.00

4.9

2.4

6.14

4.73

kpa

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.15

1.98

2.1

2.3

7.65

7.12

mmol/l

0.29

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.34

1.96

2.4

1.6

1.19

1.21

mmol/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

488

1.41

1.96

1.7

1.6

0.36

0.33

mg/l

0.11

231

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1.95

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

149

1.76

1.95

1.2

4.38

3.06

u/ml

0.38

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

149

1.76

1.95

1.2

33.00

1.90

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.12

1.92

1.3

1.1

—

(3018572) Chloride [Moles/volume] in Blood

243

1.58

1.91

7.1

8.1

104.39

105.49

mmol/l

0.85

215

(3039000) Anion gap in Blood by calculation

243

1.58

1.91

7.1

8.1

11.94

11.11

mmol/l

0.87

215

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

261

1.55

1.85

1.5

1.7

2.26

4.39

iu/l

2.24

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

122

1.81

1.84

1.0

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.54

1.84

1.2

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.13

1.82

1.1

1.5

112.86

96.78

ng/l

0.32

(3016018) Differential panel - Cerebral spinal fluid

145

1.74

1.81

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

2.58

1.80

1.1

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.96

1.80

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.10

1.76

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.92

1.72

1.3

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

1.2

0.04

0.02

u/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.85

1.71

2.4

3.1

0.40

0.38

u/field

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.00

1.71

0.0

1.0

—

0.39

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.07

1.70

1.2

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.01

1.69

1.2

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

1.68

0.0

1.0

—

1.52

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.81

1.65

1.7

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

142

1.70

1.65

1.1

1.3

—

nmol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.04

1.64

4.5

4.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

221

1.55

1.63

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.39

1.61

1.2

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

295

1.47

1.61

2.7

1.9

—

(3033099) Centromere Ab [Titer] in Serum

3.01

1.58

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.01

1.58

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.70

1.58

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

372

1.41

1.57

4.9

4.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

114

1.76

1.56

1.5

1.1

—

(3019150) Specific gravity of Urine by Refractometry

348

3107

1.15

1.56

5.3

3.8

1.02

kg/l

1.39

255

2071

(3002079) Sodium [Moles/time] in 24 hour Urine

2.28

1.55

1.6

1.4

147.60

179.17

mmol/24h

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

200

1.56

1.54

1.5

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

785

1.28

1.53

2.4

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.60

1.51

1.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

308

1.44

1.50

1.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.86

1.50

2.3

1.4

1.16

1.20

mmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

548

1.33

1.50

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.44

1.48

1.1

1.2

—

1.60

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.44

1.48

1.0

1.1

108.56

262.49

iu/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

1.45

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

294

1.44

1.45

1.5

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.98

1.43

1.2

1.5

—

(3016879) Cocaine [Presence] in Urine

278

1.45

1.43

1.5

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.31

1.43

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

304

1.43

1.41

1.6

1.2

—

(4195642) Thrombophilia screening test

142

1.63

1.38

1.3

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

119

1.69

1.38

1.4

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

9.86

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.97

1.33

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.97

1.33

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

721

1.26

1.31

2.2

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

129

1.64

1.30

1.0

1.1

3.31

6.47

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

2.36

1.29

1.1

1.4

7.62

8.53

mmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.78

1.28

1.0

1.1

23.86

38.23

iu/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.78

1.28

1.6

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.29

1.27

1.3

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.29

1.27

1.8

71.25

253.71

nmol/24h

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

485

1.31

1.25

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.23

1.24

1.4

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

108

1.67

1.22

1.1

1.2

—

(3018133) Calcium [Moles/volume] in Urine

2.64

1.21

2.8

1.9

5.14

3.66

mmol/l

—

(3027008) Opiates [Presence] in Urine

298

1.39

1.19

1.5

1.8

—

(44790047) Parainfluenza type 1 nucleic acid detection

133

1.59

1.17

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

133

1.59

1.17

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

133

1.59

1.17

1.8

1.9

—

(44790049) Parainfluenza type 3 nucleic acid detection

133

1.59

1.17

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

133

1.59

1.17

1.4

1.5

—

(3027944) Amphetamines [Presence] in Urine

299

1.38

1.17

1.5

1.8

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.01

1.16

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.06

1.15

1.3

1.1

—

(40758292) HTLV I+II Ab panel - Serum

2.50

1.15

1.4

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.34

1.12

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.26

1.10

2.4

1.5

9.64

8.96

ug/l

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

193

1.46

1.09

1.5

1.2

444.93

246.95

u/ml

1.39

110

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.38

1.09

1.4

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.93

1.06

2.1

1.5

1.89

2.02

umol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

154

1.50

1.04

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.28

1.03

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

2.28

1.03

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

299

1.35

1.01

1.5

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

994

10284

0.91

1.01

32.1

19.5

331.38

332.73

g/l

4.12

987

10201

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.65

1.00

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.00

1.00

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

107

1.59

0.99

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.18

0.98

1.2

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.67

0.98

1.1

1.2

—

(44806420) Estimation of glomerular filtration rate

100

1.61

0.96

2.6

2.7

—

(3008898) HLA-B27 [Presence]

341

0.70

0.96

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.78

0.94

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.90

0.94

1.4

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

125

1.53

0.94

1.1

0.26

2.11

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.72

0.92

2.7

1.5

4.86

5.56

u/l

0.41

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

117

1005

1.18

0.92

2.4

2.7

56.81

66.84

ml/min/173m2

1.97

430

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

135

1.49

0.89

1.5

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

361

1.28

0.86

3.0

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

326

1.30

0.85

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

326

1.30

0.85

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

239

1.35

0.84

1.6

—

(21494755) Public health laboratory ask at order entry panel

798

0.82

0.84

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1056

10260

1.08

0.83

32.2

18.5

14.02

13.65

12.63

1044

10102

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.70

0.82

1.8

2.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

320

1.29

0.81

4.4

3.3

29.22

26.88

mg/l

0.17

214

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

172

1.40

0.81

2.4

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

181

1.39

0.80

1.6

1.3

152.44

169.14

au/ml

—

(42529406) Shigella sp [Presence] in Stool by Culture

330

1.28

0.79

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.77

0.76

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

467

4409

1.08

0.76

3.8

3.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.70

0.75

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.09

0.74

1.4

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.09

0.74

1.0

1.2

44.34

56.81

mg/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

184

1.36

0.74

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

133

1.43

0.73

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.85

0.73

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.80

0.72

1.7

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1.53

0.72

1.1

2.0

3.35

8.81

umol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

541

5147

1.08

0.72

4.6

4.9

22.96

21.81

0.93

295

2761

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

618

1.19

0.72

3.3

3.5

192.03

3961.42

u/ml

1.24

534

(3019832) Treponema pallidum Ab [Presence] in Serum

684

1.18

0.71

1.7

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.93

0.70

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

137

1222

1.13

0.69

1.5

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.85

0.68

1.0

1.4

31.12

24.36

g/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.67

0.68

1.0

1.1

2109.43

1541.17

miu/ml

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.63

0.67

1.1

2.0

37.00

31.16

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.52

0.66

1.2

1.5

1.28

1.10

nmol/l

—

(3006653) Thiamine [Moles/volume] in Blood

1.58

0.65

1.1

1.3

142.55

141.71

nmol/l

0.02

(3034426) Prothrombin time (PT)

1.73

0.64

1.2

1.3

26.20

27.14

—

(3011288) Drugs identified in Urine by Screen method Nominal

207

1.31

0.64

1.8

2.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

112

1.43

0.63

1.3

—

(3005570) Glucose [Moles/volume] in Urine

121

1.41

0.62

1.7

—

(3006245) CD3-CD19+ cells/cells in Blood

1.67

0.61

1.4

2.8

6.80

9.37

—

(40768793) Breast Pathology biopsy report

262

1.26

0.61

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

114

1.41

0.59

1.4

24.50

28.38

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.57

0.58

1.3

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.51

0.58

1.6

2.1

—

921.40

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.67

0.56

1.0

—

(1175426) CD3 cells/Lymphocytes in Blood

1.51

0.56

1.2

2.3

74.45

71.56

0.41

(40768441) Liver Pathology biopsy report

1.45

0.55

1.1

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.54

0.53

1.2

0.32

0.29

g/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

205

1.27

0.52

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.61

0.52

2.0

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

100

0.60

0.51

2.0

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.50

0.51

1.0

1.4

—

(3028433) Virus identified in Specimen by Culture

1.50

0.51

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

399

1.18

0.49

3.9

1.5

1.75

4.74

mg/l

2.86

299

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

101

1.39

0.49

1.6

1.3

121.96

165.05

pmol/l

1.02

101

(40768800) Prostate Pathology biopsy report

484

0.84

0.47

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.39

0.46

1.5

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

141

0.71

0.45

1.6

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.61

0.43

1.0

1.6

22.80

14.17

pmol/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.61

0.43

2.0

2.5

0.58

0.61

mmol/l

—

(4198724) Urine methamphetamine measurement

1.61

0.43

1.2

1.7

—

(3017704) Immunofixation for Urine

1.43

0.41

1.0

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.52

0.41

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

105

1.34

0.41

1.1

1.0

4.87

1.01

u/ml

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.47

0.40

1.0

1.2

18.50

11.97

g/l

—

(3044007) Cell count panel - Peritoneal fluid

1.43

0.39

1.2

2.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

2.5

—

93.54

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.39

0.0

1.6

—

7.71

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

114

0.70

0.37

1.9

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.39

0.37

1.7

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.39

0.37

4.0

3.0

0.55

1.15

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.29

0.36

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

198

1.22

0.36

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

321

0.84

0.36

1.2

1.1

1.46

1.52

g/l

0.64

321

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.34

0.34

1.2

1.0

—

(3003694) ABO and Rh group [Type] in Blood

375

3616

1.05

0.33

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

164

1.22

0.32

1.5

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

130

1215

1.08

0.32

1.6

1.4

—

(1002224) Polysomnography panel

475

1.12

0.31

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

240

1.17

0.30

1.5

1.4

—

(3024263) Appearance of Synovial fluid

1.34

0.30

2.1

1.6

—

(4268621) Lupus anticoagulant assay

111

1.26

0.30

2.3

2.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

150

1418

1.06

0.28

2.7

2.3

13.44

13.18

nmol/l

0.13

134

1267

(1617658) Protocol used for examination of sentinel lymph nodes

1.30

0.28

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

834

0.92

0.28

1.5

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.27

0.26

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.28

0.26

3.1

1.4

75.18

86.76

umol/l

0.85

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

123

1.22

0.25

1.1

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

116

1.21

0.22

1.1

0.29

1.33

u/ml

—

(3023410) Appearance of Cerebral spinal fluid

135

1.19

0.21

1.3

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

93.54

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

1.86

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.20

0.19

1.3

1.2

11.00

9.94

mm/h

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.20

0.19

5.2

2.4

60.67

50.88

umol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.21

0.19

1.1

3.62

2.50

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.24

0.18

1.1

—

(3025130) Human papilloma virus identified in Specimen

109

1.19

0.18

1.5

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.21

0.18

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.79

0.15

1.8

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.13

0.15

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

247

1.09

0.13

1.1

1.3

247.67

191.72

miu/ml

—

102

(4281824) Cell count and differential, peritoneal fluid

115

0.87

0.10

1.4

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.03

0.08

1.5

—

(44813793) Dust mix specific IgE antibody measurement

1.04

0.08

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.04

0.07

1.3

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.05

0.07

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

280

1.04

0.03

1.9

1.6

—

(4034850) Laboratory test

397

0.98

0.01

10.3

8.8

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

104

1.06

0.01

2.0

3.4

13.42

13.13

0.33

104

(3002523) Influenza virus A Ag [Presence] in Specimen

174

1.03

0.00

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

114

0.96

0.00

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

296

1.01

0.00

1.5

1.3

2.85

21.05

e6/l

0.96

222

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

304

0.99

0.00

1.5

1.4

754.14

652.68

e6/l

0.08

241

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

342

0.99

0.00

2.1

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

175

1.03

0.00

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.87

0.00

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

9.38

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

4.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.94

-0.00

1.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3047189) Immunofixation for 24 hour Urine

0.97

-0.00

2.3

1.9

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.95

-0.00

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

370

1.00

-0.00

2.0

1.7

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.16

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

140

1.00

-0.00

1.2

1.0

3.40

2.25

eliau/ml

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

0.33

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.92

-0.00

1.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

286.94

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.6

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.2

—

1.33

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

342.67

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

2.03

—

(3022475) Manganese [Moles/volume] in Blood

0.00

-0.00

0.0

2.0

—

0.17

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_RBBB and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_RBBB	1.7 [1.49, 1.94]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.141

During the follow-up period (1.1.1998 — 31.12.2019), 1067 out of 3047 females with I9_RBBB died.

Males

Parameter	HR [95% CI]	p-value
I9_RBBB	1.463 [1.27, 1.69]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 1193 out of 3879 males with I9_RBBB died.

Mortality risk

Mortality risk for people of age

years, who have I9_RBBB.

N-year risk	Females	Males
1	0.146%	0.279%
5	0.97%	1.671%
10	2.426%	4.319%
15	4.593%	8.042%
20	7.591%	13.486%

Relationships between endpoints

↥

Index endpoint: I9_RBBB – Right bundle-branch block

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Right bundle-branch block

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints